Breath test could revolutionize lung cancer screening

NCT ID NCT06016569

Recruiting now Diagnosis Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a breath test can detect lung cancer early in people at high risk. Researchers will collect breath samples from 3,200 current or former smokers aged 55-74 and compare the results to standard low-dose CT scans. If the breath test works well, it could offer a cheaper, easier way to screen for lung cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a simple, low-cost breath test to screen for lung cancer, potentially reducing unnecessary procedures and deaths.
What could go wrong: This is an early validation study, not a treatment trial. The breath test may not be accurate enough to replace CT scans, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

General University Hospital in Prague
NOT_YET_RECRUITING

Prague, 12808, Czechia
Masaryk Memorial Cancer Institute
RECRUITING

Brno, 65653, Czechia
University Hospital
NOT_YET_RECRUITING

Olomouc, 77900, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.